BioFactura Expands Frederick Lease to 17K SF  

BioFactura, Inc. has expanded its lease with St. John Properties, Inc. at Riverside Tech Park in Frederick, Maryland. The biotechnology firm secured an additional 12,000 square feet, bringing its total space to 17,520 square feet. This expansion follows a $78 million contract from BARDA to develop its Smallpox Biodefense Therapeutic.  

“The I-270 corridor is ranked in the top five places nationally for the recruitment of life sciences talent, and that played a major role in our original decision to move to Frederick,” said Dr. Jeffrey Hausfeld, BioFactura’s chairman of the Board and Chief Medical Officer. “The region provides an affordable lifestyle with considerably less congestion than a building located closer to Washington, D.C. As a manufacturer and distributor of pharmaceuticals, the building’s flexible layout, including rear loading capabilities, perfectly suits our needs.” The new facility is slated to open this fall.